Search Results - "Anti-Inflammatory Agents therapeutic use"

Source: Ben Abdallah, H, Seeler, S, Bregnhøj, A, Ghatnekar, G, Kristensen, L S, Iversen, L & Johansen, C 2023, ' Heat shock protein 90 inhibitor RGRN-305 potently attenuates skin inflammation ', Frontiers in Immunology, vol. 14, pp. 1128897 . https://doi.org/10.3389/fimmu.2023.1128897

Subject Terms: HSP90 Heat-Shock Proteins/antagonists & inhibitors, Interleukin-6, Inflammation/metabolism, Immunology, Antineoplastic Agents/therapeutic use, Dermatitis/drug therapy, Anti-Inflammatory Agents/therapeutic use, Mice, Psoriasis/drug therapy, Quality of Life, Animals, Humans, Immunology and Allergy, Skin Diseases/drug therapy

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b922e15fa920622df0809583390194e4
https://doi.org/10.3389/fimmu.2023.1128897

4

Abdominal pain in Finnish young adults with juvenile idiopathic arthritis

Authors: Katariina Rebane, Anna-Kaisa Tuomi, Hannu Kautiainen, Suvi Peltoniemi, Mia Glerup, Kristiina Aalto

Contributors: HUS Children and Adolescents, Children's Hospital, University of Helsinki, HUS Inflammation Center, Reumatologian yksikkö

Source: Rebane, K, Tuomi, A-K, Kautiainen, H, Peltoniemi, S, Glerup, M & Aalto, K 2022, ' Abdominal pain in Finnish young adults with juvenile idiopathic arthritis ', Scandinavian Journal of Gastroenterology, vol. 57, no. 10, pp. 1189-1194 . https://doi.org/10.1080/00365521.2022.2072691

Subject Terms: young adults, Adult, Abdominal pain, Methotrexate/therapeutic use, Sulfasalazine/therapeutic use, Finland/epidemiology, Anti-Inflammatory Agents, CHILDREN, Antirheumatic Agents/therapeutic use, Anti-Inflammatory Agents/therapeutic use, outcome measures, Young Adult, QUALITY-OF-LIFE, EPIDEMIOLOGY, Humans, POPULATION, Fatigue, Finland, ASSOCIATIONS, synthetic disease modifying antirheumatic drugs, RISK, Anti-Inflammatory Agents, Non-Steroidal, Gastroenterology, Arthritis, Juvenile/complications, Arthritis, Juvenile, RHEUMATOID-ARTHRITIS, PREVALENCE, Abdominal Pain, Abdominal Pain/etiology, health-related quality of life, Sulfasalazine, Methotrexate, 3121 General medicine, internal medicine and other clinical medicine, Antirheumatic Agents, juvenile idiopathic arthritis, Quality of Life, Female, Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, INFLAMMATORY-BOWEL-DISEASE, FATIGUE SEVERITY SCALE, Follow-Up Studies

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf5600b38f0bf70bc5fcb99d3dc2014e
https://doi.org/10.1080/00365521.2022.2072691

5

Radioprotective Effect of Nigella Sativa Oil on Heart Tissues of Rats Exposed to Irradition

Authors: Mehmet Kaplan, Elif Demir, Fethi Yavuz, Gizem Ilgin Kaplan, Mehmet Resit Taysi, Seyithan Taysi, Mehmet Murat Sucu

Source: International Journal of Cardiovascular Sciences, Volume: 35, Issue: 2, Pages: 214-219, Published: 07 JAN 2022
International Journal of Cardiovascular Sciences, Issue: ahead, Published: 07 JAN 2022
International Journal of Cardiovascular Sciences v.35 n.2 2022
International Journal of Cardiovascular Sciences
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC

Subject Terms: Radiation, Plants, Medicinal, Radiation, Effects, Anti-Inflammatory Agents/therapeutic use, Nigella Sativa Oil, Rats

File Description: text/html

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8320d7774e2739a5a6d3f01842708c01
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472022000200214&lng=en&tlng=en

6

Recurrent autoimmune hypophysitis treated with rituximab: a case report

Authors: Maria Kruse, Thomas Bastholm Olesen, Ljubo Markovic, Dorte Glintborg, Marianne Skovsager Andersen

Source: Journal of Medical Case Reports
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-6 (2021)
Kruse, M, Olesen, T B, Markovic, L, Glintborg, D & Andersen, M S 2021, ' Recurrent autoimmune hypophysitis treated with rituximab : a case report ', Journal of Medical Case Reports, vol. 15, 591 . https://doi.org/10.1186/s13256-021-03146-0

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::188b03786d32d82f614777e4dafd85e8
http://europepmc.org/articles/PMC8672614

7

Report

Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans

Authors: Calabrese, Cecilia, Corcione, Nadia, Rea, Gaetano, Stefanelli, Francesco, Meoli, Ilernando, Vatrella, Alessandro

Source: Jornal Brasileiro de Pneumologia. June 2016 42(3)

Subject Terms: Bronchiolitis obliterans/therapy, Infection/complications, Adrenergic beta-2 receptor antagonists/therapeutic use, Administration, inhalation, Anti-inflammatory agents/therapeutic use, Muscarinic antagonists/therapeutic use, Lung diseases/rehabilitation

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-37132016000300228

Accede al texto completo

PDF Full Text

8

The immunometabolic role of indoleamine 2,3-dioxygenase in atherosclerotic cardiovascular disease: immune homeostatic mechanisms in the artery wall

Authors: Daniel F. J. Ketelhuth

Source: Ketelhuth, D F J 2019, ' The immunometabolic role of indoleamine 2 3-dioxygenase in atherosclerotic cardiovascular disease : immune homeostatic mechanisms in the artery wall ', Cardiovascular Research, vol. 115, no. 9, pp. 1408-1415 . https://doi.org/10.1093/cvr/cvz067

Subject Terms: Kynurenine pathway, Physiology, Anti-Inflammatory Agents, Inflammation, Disease, Anti-Inflammatory Agents/therapeutic use, IDO, Immunomodulation, Energy Metabolism/drug effects, chemistry.chemical_compound, Immune system, Inflammation/drug therapy, Physiology (medical), Diabetes mellitus, medicine, Indoleamine-Pyrrole 2,3,-Dioxygenase, Humans, Animals, Indoleamine 2,3-dioxygenase, Kynurenine, Immunomodulation/drug effects, Immunometabolism, business.industry, Tryptophan, Atherosclerosis/drug therapy, Arteries, Atherosclerosis, medicine.disease, Plaque, Atherosclerotic, Up-Regulation, Immune System/drug effects, chemistry, Arteries/drug effects, Immune System, Immunology, Tryptophan/immunology, Indoleamine-Pyrrole 2,3,-Dioxygenase/immunology, medicine.symptom, Energy Metabolism, Cardiology and Cardiovascular Medicine, business, Homeostasis, Signal Transduction

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::754e76d35f41858a7875f9f81b073d6d
https://doi.org/10.1093/cvr/cvz067

HTML Full Text PDF Full Text

9

Nanoimmunotherapy to treat ischaemic heart disease

Source: Nature Reviews. Cardiology. 16(1):21-32

Subject Terms: Atherosclerosis/diagnosis, Myocardial Ischemia/diagnosis, Immunity, SDG 3 – Goede gezondheid en welzijn, Anti-Inflammatory Agents/therapeutic use, Nanomedicine/methods, Innate/drug effects, SDG 3 - Good Health and Well-being, Signal Transduction/drug effects, Immunotherapy/methods, Animals, Humans, Molecular Targeted Therapy, Inflammation Mediators/antagonists & inhibitors

Access URL: https://explore.openaire.eu/search/publication?articleId=dris___01180::ccd8c62127119d545c20045485578d24
https://doi.org/10.1038/s41569-018-0073-1

10

Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events

Authors: Stephan Windecker, Heiner C. Bucher, Barbara E. Stähli, François Mach, Thomas F. Lüscher, Soheila Aghlmandi, Nicolas Rodondi, Arnold von Eckardstein, David Carballo, David Nanchen, Christian M. Matter, Sebastian Carballo, Roland Klingenberg, Ulf Landmesser, Baris Gencer, Lorenz Räber

Contributors: University of Zurich, Klingenberg, Roland

Source: Atherosclerosis, vol. 320, pp. 31-37
Klingenberg, Roland; Aghlmandi, Soheila; Gencer, Baris; Nanchen, David; Räber, Lorenz; Carballo, David; Carballo, Sebastian; Stähli, Barbara E; Landmesser, Ulf; Rodondi, Nicolas; Mach, François; Windecker, Stephan; Bucher, Heiner C; von Eckardstein, Arnold; Lüscher, Thomas F; Matter, Christian M (2021). Residual inflammatory risk at 12 months after acute coronary syndromes is frequent and associated with combined adverse events. Atherosclerosis, 320, pp. 31-37. Elsevier 10.1016/j.atherosclerosis.2021.01.012 <http://dx.doi.org/10.1016/j.atherosclerosis.2021.01.012>

Subject Terms: 0301 basic medicine, medicine.medical_specialty, Intervention trials, Acute Coronary Syndrome/diagnosis, Acute Coronary Syndrome/epidemiology, Acute Coronary Syndrome/therapy, Anti-Inflammatory Agents/therapeutic use, Biomarkers, C-Reactive Protein/analysis, Humans, Myocardial Infarction/diagnosis, Myocardial Infarction/epidemiology, CRP, Inflammation, Myocardial infarction, Risk factors, Anti-Inflammatory Agents, Myocardial Infarction, 610 Medicine & health, 030204 cardiovascular system & hematology, Demographic data, 2705 Cardiology and Cardiovascular Medicine, 11459 Center for Molecular Cardiology, 03 medical and health sciences, 0302 clinical medicine, 360 Social problems & social services, Internal medicine, medicine, cardiovascular diseases, Acute Coronary Syndrome, Adverse effect, 10038 Institute of Clinical Chemistry, business.industry, medicine.disease, Coronary revascularization, C-Reactive Protein, 030104 developmental biology, Cohort, 10209 Clinic for Cardiology, 570 Life sciences, biology, Cardiology and Cardiovascular Medicine, business

File Description: application/pdf; 1-s2.0-S002191502100023X-main.pdf - application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6bd84add83495ed1e1bcdb3fe2407a
https://serval.unil.ch/notice/serval:BIB_541186F9F92C

11

When Therapeutic IgA Antibodies Might Come of Age

Authors: Delphine Sterlin, Guy Gorochov

Contributors: Anticorps en thérapie et pathologie - Antibodies in Therapy and Pathology, Institut Pasteur [Paris] (IP)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre d'Immunologie et des Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), D.S. was supported for this work by an Institut Pasteur/Assistance Publique – Hôpitaux de Paris (APHP) interface fellowship. The Gorochov Laboratory is financed by Inserm, APHP (PHRC-20-0375), Sorbonne Université (SARS-CoV-2 Program), Région Île de France Domaines d’Intérêt Majeur (DIM Thérapie Génique), Fondation de France, and Agence Nationale de la Recherche (iCOVID ANR-20-COVI-0025)., Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Pasteur [Paris], Centre d'Immunologie et de Maladies Infectieuses (CIMI), Gestionnaire, HAL Sorbonne Université 5

Source: Pharmacology
Pharmacology, 2021, 106 (1-2), pp.9-19. ⟨10.1159/000510251⟩
Pharmacology, Karger, 2021, 106 (1-2), pp.9-19. ⟨10.1159/000510251⟩

Subject Terms: Immunoglobulin A, MESH: Immunoglobulin A / adverse effects, MESH: Neoplasms / immunology, medicine.medical_treatment, Anti-Inflammatory Agents, MESH: SARS-CoV-2 / immunology, Gut flora, medicine.disease_cause, 030226 pharmacology & pharmacy, Therapeutic antibody, Mice, MESH: Antiviral Agents / therapeutic use, Antineoplastic Agents, Immunological, 0302 clinical medicine, Neoplasms, Rotavirus, MESH: Anti-Inflammatory Agents / therapeutic use, MESH: Animals, biology, MESH: Antibodies, Monoclonal / therapeutic use, Poliovirus, MESH: Inflammation / drug therapy, Antibodies, Monoclonal, General Medicine, MESH: COVID-19 / virology, 3. Good health, Host-Pathogen Interactions, [SDV.IMM]Life Sciences [q-bio]/Immunology, Immunotherapy, Antibody, Primary antibody deficiency, MESH: Antineoplastic Agents, Immunological / therapeutic use, MESH: Immunoglobulin A / therapeutic use, [SDV.IMM] Life Sciences [q-bio]/Immunology, MESH: Neoplasms / drug therapy, Bioengineering, Antiviral Agents, Virus, MESH: Antiviral Agents / adverse effects, 03 medical and health sciences, Immune system, medicine, Animals, Humans, MESH: Immunotherapy* / adverse effects, MESH: Mice, Inflammation, Pharmacology, MESH: Inflammation / immunology, MESH: Humans, SARS-CoV-2, business.industry, MESH: Host-Pathogen Interactions, COVID-19, MESH: Antibodies, Monoclonal / adverse effects, biology.organism_classification, MESH: COVID-19 / immunology, COVID-19 Drug Treatment, MESH: COVID-19 / drug therapy, Immunology, biology.protein, business, 030217 neurology & neurosurgery

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9a12b1182e8d150ab11b2aa001c856
https://hal.sorbonne-universite.fr/hal-03139698

12

Monocytes as potential therapeutic sensors in glucocorticoid-treated newly diagnosed immune thrombocytopenia

Authors: Rick Kapur

Contributors: Landsteiner Laboratory

Source: British journal of haematology, 192(2), 233-234. Wiley-Blackwell

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bca2c8ecc1148433ccf7ed9b9e364f49
https://pure.amc.nl/en/publications/monocytes-as-potential-therapeutic-sensors-in-glucocorticoidtreated-newly-diagnosed-immune-thrombocytopenia(dc038e4b-248c-4617-8b4b-b113898c2b0b).html

13

Possible treatment and strategies for COVID-19:review and assessment

Authors: Trivedi, N, Verma, A, Kumar, D

Source: Trivedi, N, Verma, A & Kumar, D 2020, ' Possible treatment and strategies for COVID-19 : review and assessment ', European review for medical and pharmacological sciences, vol. 24, no. 23, pp. 12593-12608 . https://doi.org/10.26355/eurrev_202012_24057

Subject Terms: Amides/therapeutic use, Ritonavir/therapeutic use, Anti-Inflammatory Agents/therapeutic use, COVID-19/drug therapy, Adenosine Monophosphate/analogs & derivatives, Complement Inactivating Agents/therapeutic use, Tetracyclines/therapeutic use, Antibodies, Neutralizing/therapeutic use, Cannabinoids/therapeutic use, Humans, Lopinavir/therapeutic use, Antiviral Agents/therapeutic use, Interferons/therapeutic use, Enzyme Inhibitors/therapeutic use, SARS-CoV-2, Immunization, Passive, Alanine/analogs & derivatives, Dexamethasone/therapeutic use, Pyrazines/therapeutic use, Anti-Bacterial Agents/therapeutic use, Drug Combinations, Antibodies, Monoclonal, Humanized/therapeutic use, Hydroxychloroquine/therapeutic use, Thiazoles/therapeutic use, Chloroquine/therapeutic use, Teicoplanin/therapeutic use, COVID-19 Vaccines/therapeutic use, Antiparasitic Agents/therapeutic use, Indoles/therapeutic use, Ivermectin/therapeutic use

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=od______3818::67e7992fccea44928baf508273a43c1b
https://www.research.manchester.ac.uk/portal/en/publications/possible-treatment-and-strategies-for-covid19(6314579b-9634-4e58-a745-0862e56f0f85).html

14

A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Individuals

Source: Pathogens and Immunity, Vol 2, Iss 3, Pp 310-334 (2017)
Pathogens & immunity, vol 2, iss 3

Subject Terms: Microbiology (medical), lcsh:Immunologic diseases. Allergy, Clinical Trials and Supportive Activities, Immunology, Rectum, Lymphoid fibrosis, Placebo, Anti-Inflammatory Agents/therapeutic use, Article, Disease Reservoirs/*virology, 03 medical and health sciences, 0302 clinical medicine, Clinical Research, Fibrosis, T-cell activation, Genetics, medicine, Clinical endpoint, lcsh:Pathology, Immunology and Allergy, 030212 general & internal medicine, Molecular Biology, 030304 developmental biology, Anti-Inflammatory Agents/*therapeutic use, 0303 health sciences, biology, business.industry, Lisinopril, Evaluation of treatments and therapeutic interventions, HIV, Angiotensin-converting enzyme, medicine.disease, 3. Good health, CD4 Lymphocyte Count, Good Health and Well Being, Infectious Diseases, Lymphatic system, medicine.anatomical_structure, 6.1 Pharmaceuticals, biology.protein, HIV/AIDS, Infection, business, lcsh:RC581-607, medicine.drug, Blood drawing, lcsh:RB1-214

File Description: application/pdf

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69aef5a84f03e5ec6a728a3a703506b1
http://paijournal.com/index.php/paijournal/article/view/207

15

Academic Journal

Rationale for anti-inflammatory therapy in dry eye syndrome

Authors: De Paiva, CS, Pflugfelder, SC

Source: Arquivos Brasileiros de Oftalmologia. December 2008 71(6)

Subject Terms: Dry eye syndromes, Inflammation, Concentration osmolar, Cyclosporine/therapeutic use, Doxycycline/therapeutic use, Cytokines/therapeutic use, Metalloproteases, Anti-Inflammatory agents/therapeutic use

File Description: text/html

Access URL: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-27492008000700017

16

Inflammation in Cardiovascular Disease: From Basic Concepts to Clinical Application

Authors: David D. Waters

Source: International Journal of Cardiovascular Sciences v.33 n.5 2020
International Journal of Cardiovascular Sciences
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
International Journal of Cardiovascular Sciences, Issue: ahead, Published: 17 JUL 2020
International Journal of Cardiovascular Sciences, Volume: 33, Issue: 5, Pages: 518-527, Published: 17 JUL 2020

File Description: application/pdf; text/html

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2537efd9066de671dee2da29f68c669
https://doi.org/10.36660/ijcs.20200048

17

Nanoimmunotherapy to treat ischaemic heart disease

Authors: Willem J. M. Mulder, Matthias Nahrendorf, Zahi A. Fayad, Carlos Pérez-Medina, Mandy M. T. van Leent, Max L. Senders, Raphaël Duivenvoorden

Contributors: Nephrology, ACS - Amsterdam Cardiovascular Sciences, ACS - Atherosclerosis & ischemic syndromes, Graduate School, 01 Internal and external specialisms, AII - Inflammatory diseases, Medical Biochemistry

Source: Nature Reviews. Cardiology, 16, 21-32
Nature Reviews. Cardiology, 16, 1, pp. 21-32
Nature reviews. Cardiology, 16(1), 21-32. Nature Publishing Group

Subject Terms: 0301 basic medicine, Anti-Inflammatory Agents, Myocardial Ischemia, Inflammation, Disease, 030204 cardiovascular system & hematology, Bioinformatics, Anti-Inflammatory Agents/therapeutic use, Nanomedicine/methods, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Immunity, Signal Transduction/drug effects, Immunopathology, medicine, Animals, Humans, Molecular Targeted Therapy, Myocardial infarction, Stroke, Innate immune system, Atherosclerosis/diagnosis, Cholesterol, business.industry, Myocardial Ischemia/diagnosis, Atherosclerosis, medicine.disease, Immunity, Innate, Innate/drug effects, Renal disorders Radboud Institute for Molecular Life Sciences [Radboudumc 11], Nanomedicine, 030104 developmental biology, chemistry, Immunotherapy/methods, Immunotherapy, Inflammation Mediators, medicine.symptom, Cardiology and Cardiovascular Medicine, business, Inflammation Mediators/antagonists & inhibitors, Signal Transduction

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfe51c13e8b863907987fd3fe17d23d8
https://doi.org/10.1038/s41569-018-0073-1

18

Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis

Authors: Bent Deleuran, Oliver Hendricks, Holger Jon Møller, Line Dam Heftdal, Alice Christiansen, Bodil Arnbak, Anne Grethe Jurik, Stinne Ravn Greisen, Anne Gitte Loft, Berit Schiøttz-Christensen, René Østgård

Source: Heftdal, L D, Loft, A G, Hendricks, O, Ashouri Christiansen, A, Schiøttz-Christensen, B, Arnbak, B, Jurik, A G, Østgård, R, Winding Deleuran, B, Møller, H J & Greisen, S R 2018, ' Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 78, no. 6, pp. 483-489 . https://doi.org/10.1080/00365513.2018.1500704
Heftdal, L D, Loft, A G, Hendricks, O, Ashouri Christiansen, A, Schiøttz-Christensen, B, Arnbak, B, Jurik, A G, Østgård, R, Winding Deleuran, B, Møller, H J & Greisen, S R 2018, ' Divergent effects on macrophage biomarkers soluble CD163 and CD206 in axial spondyloarthritis ', Scandinavian Journal of Clnical and Laboratory Investigation, vol. 78, no. 6, pp. 483-489 . https://doi.org/10.1080/00365513.2018.1500704

Subject Terms: Male, 0301 basic medicine, Mannose-Binding Lectins/blood, Clinical Biochemistry, Anti-Inflammatory Agents, receptors, Gene Expression, Anti-Inflammatory Agents/therapeutic use, Receptors, Cell Surface/blood, Cohort Studies, Macrophages/drug effects, 0302 clinical medicine, Cell Movement, polycyclic compounds, Soluble cd163, Axial spondyloarthritis, skin and connective tissue diseases, Receptor, mannose receptor, integumentary system, Chemistry, Lectins, C-Type/blood, food and beverages, General Medicine, Middle Aged, macrophages, spondylarthritis, Female, medicine.symptom, Infiltration (medical), Mannose Receptor, Mannose receptor, Adult, Antigens, CD/blood, Antigens, Differentiation, Myelomonocytic, Receptors, Cell Surface, Inflammation, 03 medical and health sciences, Spondylarthritis/diagnosis, Antigens, CD, Adalimumab/therapeutic use, Spondylarthritis, medicine, Humans, Lectins, C-Type, Sacroiliitis, Antigens, Differentiation, Myelomonocytic/blood, scavenger, 030203 arthritis & rheumatology, Sacroiliitis/diagnosis, Tumor Necrosis Factor-alpha, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Macrophages, Adalimumab, biomarkers, Cell movement, Macrophage Activation, medicine.disease, Radiography, Mannose-Binding Lectins, Early Diagnosis, 030104 developmental biology, Solubility, Cancer research, CD163, Biomarkers, Biomarkers/blood

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f70fcdb90f5b06b8bf0159dc9b79660b
https://doi.org/10.1080/00365513.2018.1500704

HTML Full Text PDF Full Text

19

Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans

Authors: Francesco Stefanelli, Gaetano Rea, Ilernando Meoli, Cecilia Calabrese, Nadia Corcione, Alessandro Vatrella

Contributors: Calabrese, C, Corcione, N, Rea, Giusi, Stefanelli, F, Meoli, I, Vatrella, A

Source: Jornal Brasileiro de Pneumologia
Jornal Brasileiro de Pneumologia, Vol 42, Iss 3, Pp 228-231

Subject Terms: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Long term treatment, medicine.drug_class, medicine.medical_treatment, Bronchiolitis obliterans, Inhaled corticosteroids, Anti-inflammatory agents/ therapeutic use, Case Report, Muscarinic antagonists/therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Anti-inflammatory agents/therapeutic use, Bronchodilator, medicine, Pulmonary rehabilitation, 030212 general & internal medicine, Bronchiolitis obliterans/therapy, Lung function, Gynecology, lcsh:RC705-779, Administration, inhalation, inhalation, business.industry, lcsh:Diseases of the respiratory system, medicine.disease, Adrenergic beta-2 receptor antagonists/therapeutic use, Infection/complications, Lung diseases/rehabilitation, 030228 respiratory system, Physical performance, Infection/complication, Anesthesia, Administration, business, Pediatric population

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be1e2d504884488af9953493a5a0c2e
http://europepmc.org/articles/PMC4984545

20

Evolving Issues in the Treatment of Depression

Authors: Andrew A. Nierenberg, Ole Köhler-Forsberg, Cristina Cusin

Source: Köhler-Forsberg, O, Cusin, C & Nierenberg, A A 2019, ' Evolving Issues in the Treatment of Depression ', JAMA-Journal of the American Medical Association, vol. 321, no. 24, pp. 2401-2402 . https://doi.org/10.1001/jama.2019.4990

Subject Terms: medicine.medical_specialty, SYMPTOMS, Mediterranean diet, MEDLINE, Anti-Inflammatory Agents, Antidepressive Agents/therapeutic use, Diet, Mediterranean, THERAPY, Anti-Inflammatory Agents/therapeutic use, Ketamine/therapeutic use, Pharmacotherapy, medicine, Humans, Psychiatry, Depression (differential diagnoses), Depressive Disorder, Major/diet therapy, Depressive Disorder, Depressive Disorder, Major, business.industry, Correction, Exercise therapy, General Medicine, Psilocybine, medicine.disease, Antidepressive Agents, Exercise Therapy, Esketamine, Major depressive disorder, Ketamine, business, Excitatory Amino Acid Antagonists/therapeutic use, Excitatory Amino Acid Antagonists, medicine.drug

Access URL: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::693d273cd27b9d13862991d045a59729
https://pubmed.ncbi.nlm.nih.gov/31742616

HTML Full Text PDF Full Text

Refine Results